|
Code
|
0818E
|
|
MA number
|
EU/1/15/1043/009
|
|
Product Form:
|
sol inj 1x0,4 ml/40 mg (striek.inj.napl.skl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
GlaxoSmithKline Trading Services Limited, Ireland
|
|
Therapeutic Class:
|
14 - BRONCHODILATANTIA, ANTIASTHMATICA
|
|
ATC:
|
| R |
RESPIRATORY SYSTEM |
| R03 |
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03D |
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03DX |
Other systemic drugs for obstructive airway diseases |
| R03DX09 |
Mepolizumab |
|
|
Shelf life:
|
36 |
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
